claim: nanoparticle vaccine for covid-19 spurs against immune response in preclinical tests
evidence_1: the nanoparticle vaccine technology leverages a unique design that's unlike the majority of other covid-19 vaccine candidates now in clinical testing.", "september 21, 2020 la jolla, ca --in a new study that demonstrates the promise of a novel vaccine approach for covid-19, scripps research scientist jiang zhu, phd, showed that his protein nanoparticle technology successfully triggered a strong immune response in mice.", "\"our vaccine design enables immune cells to encounter these proteins in a more natural conformation--embedded on a spherical particle--so they'll know what to do when they face the virus in real life.\"", 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  "the study, \" self-assembling nanoparticles presenting receptor binding domain and stabilized spike as next-generation covid-19 vaccines , \" was authored by linling he, xiaohe lin, ying wang, ciril abraham, cindy sou, timothy ngo, yi zhang, ian wilson and jiang zhu.")